Concepedia

Xuesheng Mo

XM

3

Publications

138

Citations

3

H-Index

2014

Active since

Affiliations

Tetra Therapeutics (United States)(Current)

West Virginia University

Northern Illinois University

Beryllium (United States)

Xuesheng Mo is an author at Tetra Therapeutics (United States) specializing in drug discovery, medicinal chemistry, and medicine.

Top concepts

MedicinePharmacologyDrug DiscoveryNatural SciencesMedicinal ChemistryChemistryBiochemistryChemical BiologyDrug DevelopmentFragile X Spectrum

Publications per year

2014–2020

3

Publications

3

Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders

Mark E. Gurney, Richard A. Nugent, Xuesheng Mo et al. · Journal of Medicinal Chemistry · 2019 · 73 citations · Full text

Drug Target, Earlier Pde4 Inhibitors, Lead Identification +17

Discovery of triazines as selective PDE4B versus PDE4D inhibitors

Timothy J. Hagen, Xuesheng Mo, Alex B. Burgin et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 48 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Natural Sciences +5

Discovery, Radiolabeling, and Evaluation of Subtype-Selective Inhibitors for Positron Emission Tomography Imaging of Brain Phosphodiesterase-4D

Yuichi Wakabayashi, Sanjay Telu, Rachel M. Dick et al. · ACS Chemical Neuroscience · 2020 · 17 citations · Full text

Rows per page

1–3 of 3